Insights Into Alignment Healthcare (ALHC) Q4: Wall Street Projections for Key Metrics

The upcoming report from Alignment Healthcare (ALHC) is expected to reveal quarterly loss of $0.18 per share, indicating an increase of 28% compared to the year-ago period. Analysts forecast revenues of $677.04 million, representing an increase of 45.5% year over year.The current level reflects no revision in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this period.Before a company reveals its earnings, it is vital to take into account any changes in earnings projections. These revisions play a pivotal role in predicting the possible reactions of investors toward the stock. Multiple empirical studies have consistently shown a strong association between trends in earnings estimates and the short-term price movements of a stock.While investors typically use consensus earnings and revenue estimates as indicators of quarterly business performance, exploring analysts' projections for specific key metrics can offer valuable insights.That said, let's delve into the average estimates of some Alignment Healthcare metrics that Wall Street analysts commonly model and monitor.The average prediction of analysts places 'Revenues- Other' at $7.48 million. The estimate indicates a year-over-year change of +17.2%.Analysts expect 'Revenues- Earned premiums' to come in at $668.26 million. The estimate indicates a change of +45.6% from the prior-year quarter.Analysts' assessment points toward 'Medical Benefit Ratio' reaching 89.4%. The estimate is in contrast to the year-ago figure of 89.4%.It is projected by analysts that the 'Health Plan Membership - Ending' will reach 185,005. The estimate compares to the year-ago value of 119,200.View all Key Company Metrics for Alignment Healthcare here>>>Shares of Alignment Healthcare have demonstrated returns of -12% over the past month compared to the Zacks S&P 500 composite's -1.8% change. With a Zacks Rank #4 (Sell), ALHC is expected to lag the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>Only $1 to See All Zacks' Buys and SellsWe're not kidding.Several years ago, we shocked our members by offering them 30-day access to all our picks for the total sum of only $1. No obligation to spend another cent.Thousands have taken advantage of this opportunity. Thousands did not - they thought there must be a catch. Yes, we do have a reason. We want you to get acquainted with our portfolio services like Surprise Trader, Stocks Under $10, Technology Innovators,and more, that closed 256 positions with double- and triple-digit gains in 2024 alone.See Stocks Now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Alignment Healthcare, Inc. (ALHC): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks